or Try an Advanced Search...

    Tumor Necrosis Stocks List

    Symbol Grade Name % Change
    CKPT C Checkpoint Therapeutics, Inc. -3.21
    AMGN B Amgen Inc. 0.48
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Epidermal Growth Factor Receptor Medicine Necrosis Tumor Necrosis Factor Antibodies Biotechnology Blood Cells Bone Bone Disease Cancer Care Cancer Immunotherapy Checkpoint Inhibitor Chemotherapy Clinic Dialysis Dow Jones Component Drugs Growth Factors Healthcare Providers Hematology

    Related ETFs - A few ETFs which own one or more of the above listed Tumor Necrosis stocks.

    Symbol Grade Name Weight
    BBH B Market Vectors Biotech ETF 15.36
    BIS D ProShares UltraShort Nasdaq Biotechnology 8.14
    IBB B iShares Nasdaq Biotechnology Index Fund 7.95
    IBBQ B Invesco Nasdaq Biotechnology ETF 7.89
    MEDX B Horizon Kinetics Medical ETF 6.05
    View all Tumor Necrosis ETFs...
    Compare ETFs
    Compare BIS to MEDX Compare IBB to IBBQ Compare IBBQ to MEDX

        Tumor Necrosis Stocks Recent News

        Date Stock Title
        Jul 5 AMGN What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
        Jul 5 AMGN EAN 2024: The role of B cells in shaping rituximab use in generalised MG
        Jul 5 AMGN Amgen: An Emerging GLP-1 Play, Modest Mid-Teens P/E With Strong Momentum
        Jul 4 AMGN NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
        Jul 4 AMGN Amgen Inc. (NASDAQ:AMGN) Shares Could Be 42% Below Their Intrinsic Value Estimate
        Jul 4 AMGN Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
        Jul 3 AMGN S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
        Jul 3 AMGN Health Care Stocks With A Long History Of Dividend Growth And Solid Yields
        Jul 2 CKPT Checkpoint resubmits FDA application for cosibelimab
        Jul 2 CKPT Checkpoint Therapeutics Resubmits Biologics License Application for Cosibelimab, Launches $12 Million Direct Share Offering
        Jul 2 CKPT Checkpoint Therapeutics looks to raise $12M through direct offering
        Jul 2 CKPT Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
        Jul 2 CKPT Checkpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab
        Jul 2 AMGN Dow Jones Falls Amid Powell Speech; Tesla Stock Surges On Deliveries
        Jul 1 AMGN Dow Jones Rallies After Economic Data; Nvidia Gets Price Target Hike
        Jul 1 AMGN 10 clinical trials to watch in the second half of 2024
        Jun 29 AMGN How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Epidermal Growth Factor Receptor Medicine Necrosis Tumor Necrosis Factor Antibodies Biotechnology Blood Cells Bone Bone Disease Cancer Care Cancer Immunotherapy Checkpoint Inhibitor Chemotherapy Clinic Dialysis Dow Jones Component Drugs Growth Factors Healthcare Providers Hematology
        Tumor Necrosis

        Tumor Necrosis is a type of cell death that occurs when cells are exposed to certain stimuli, such as radiation, chemotherapy, or certain drugs. It is a form of programmed cell death that is triggered by the body's own immune system in response to the presence of a tumor. Tumor Necrosis can be beneficial, as it can help to reduce the size of a tumor and prevent it from spreading.

        Browse All Tags